Dysplasia of cervix uteri, unspecified
ICD-10 N87.9 is a billable code used to indicate a diagnosis of dysplasia of cervix uteri, unspecified.
Dysplasia of the cervix uteri refers to abnormal changes in the cells on the surface of the cervix, which can be precursors to cervical cancer. The condition is often detected through Pap smears or cervical biopsies. Dysplasia is categorized into mild, moderate, and severe forms, with the unspecified code (N87.9) indicating that the degree of dysplasia has not been specified. This condition is typically associated with human papillomavirus (HPV) infection, which is a significant risk factor for cervical cancer. Women diagnosed with cervical dysplasia may experience no symptoms, making regular screening essential for early detection. Management may include monitoring, further diagnostic procedures, or treatment options such as excisional procedures or ablation, depending on the severity of the dysplasia. The importance of follow-up care and patient education regarding HPV vaccination and screening guidelines is crucial in managing this condition effectively.
Detailed documentation of Pap smear results, biopsy findings, and treatment plans.
Routine screening, follow-up after abnormal Pap results, and management of dysplasia.
Ensure accurate staging and follow-up coding based on the severity of dysplasia.
Comprehensive reports on biopsy results and histological findings.
Evaluation of cervical biopsies and reporting of dysplastic changes.
Clear communication of findings to referring physicians for accurate coding.
Used for routine Pap smears to detect dysplasia.
Document the date of the procedure and results.
Gynecologists should ensure accurate coding based on findings.
N87.9 indicates unspecified dysplasia of the cervix uteri, meaning the severity of the dysplastic changes has not been specified.
